Fig. 1From: Impact of multimorbidity on the first ts/bDMARD effectiveness and retention rate after two years of follow-up in patients with rheumatoid arthritis from the BIOBADASER registryFirst ts/bDMARD retention rate based on the presence of multimorbidity according to the Charlson Comorbidity Index scoreBack to article page